Improving Diagnostic Coincidence Rate of Graves’ Disease by Ultrasound Examination with Clinical Symptoms

doi:10.37015/AUDT.2021.190014

Abstract

Abstract:

Objective: Combining ultrasound parameters with patient’s clinical symptoms to explore the feasibility of improving the diagnostic coincidence rate of hyperthyroidism.
Methods: A total of 179 untreated patients with diffuse echogenic changes of the thyroid on ultrasound and abnormal laboratory examinations were enrolled this study. There were 119 cases of hyperthyroidism, 29 cases of subclinical hyperthyroidism, 26 cases of subclinical hypothyroidism, and 5 cases of Hashimoto’s thyroiditis with clinically confirmed diagnosis. The thyroid volume, blood supply grade, peak velocity of the superior thyroid artery (STA) by ultrasound, heart rate (HR), and clinical symptoms was used to determine the optimal indicators for the diagnosis of hyperthyroidism, and to compare these indicators (study group) with the previous ultrasound criteria reported in the literature (control group).
Results: According to logistic regression analysis, from all the factors studied, hyperthyroidism symptoms had the most significant correlation with the diagnosis of hyperthyroidism (P = 0.001), followed by STA peak velocity (P = 0.005), HR (P = 0.009), echogenicity(P = 0.015)and blood flow Grade III (P = 0.041) in order of importance, the other factors include thyroid volume, blood flow Grade I and II were not correlated with the diagnosis of hyperthyroidism (P > 0.05). The diagnostic coincidence rate of hyperthyroidism by increased STA peak velocity was 85.7% (102/119), while the hyperthyroidism symptoms significantly increased the diagnostic coincidence rate to 95.8% (114/119). Comparing the study group to the control group, the area under the receiver operating curve (ROC) was 0.993 vs 0.899 (Z = 3.868, P = 0.001). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were 89.92% vs. 68.91%, 96.67% vs. 96.67%, 92.18% vs. 78.21%, 98.17% vs. 97.62%, and 82.80% vs. 61.05%, respectively.
Conclusions: The optimal indicators for the diagnosis of hyperthyroidism is the presence of hyperthyroidism symptoms in untreated patients with diffuse echogenic changes of the thyroid, followed by increased STA peak velocity. This suggests that ultrasound doctors should carefully considerate clinical information and instead of just limited to ultrasound itself. By combining ultrasound parameters with the clinical manifestations of patients, the diagnostic coincidence rate can be truly improved.

Key words: Hyperthyroidism; Clinical symptoms; Blood flow velocity; Superior thyroid artery; Ultrasound

Bingyan Liu, MD, Jie Hu, MD, Wei Liao, MD, Donglin Wang, MD, Xiangxiang Jing, MD. Improving Diagnostic Coincidence Rate of Graves’ Disease by Ultrasound Examination with Clinical Symptoms. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(2): 87-94.

References

[1]	Kimura T, Matsuki M, Kaneto H, Mune T, Kaku K. Influence of thyroid volume on the effect of methimazole in Japanese subjects with mild Graves' disease. Eur J Intern Med. 2016; 36:e31-e32.
[2]	Singh PK, Sharma SK, Sinha A, Dutta P. Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India. Clin Rheumato 2016; 35:765-769.
[3]	Kim TK, Lee EJ. The value of the mean peak systolic velocity of the superior thyroidal artery in the differential diagnosis of thyrotoxicosis. Ultrasonography 2015; 34:292-296.
[4]	Pishdad P, Pishdad GR, Tavanaa S, Pishdad R, Jalli R. Thyroid ultrasonography in differentiation between graves’ disease and hashimoto’s thyroiditis. J Biomed Phys Eng 2017; 7:21-26.
[5]	Peng X, Wu S, Bie C, Tang H, Xiong Z, Tang S. Mean peak systolic velocity of superior thyroid artery for the differential diagnosis of thyrotoxicosis: a diagnostic meta-analysis. BMC Endocr Disord 2019; 19:56.
[6]	Liu BY, Hu J, Wang DL, Liao W. The coincidence rate of diagnosis of hyperthyroidism in measuring peck velocity of the superior thyroid artery using different methods of ultrasound. J Pract Med 2015; 31:215-218.
[7]	Zhang GS, Ding Y, Sun Y. Diagnosis of hyperthyroidism by product of the peak velocity of superior thyroid artery and heart rate. Chinese J Ultrasound Med 2003; 11-13.
[8]	Zhou ZG. Application of the product of the peck velocity of the superior thyroid artery and heart rate in the diagnosis of hyperthyroidism. China Health Care and Nutrition 2013; 12:7741.
[9]	Qian T. Application of the product of the peck velocity of the superior thyroid artery and heart Rate in the diagnosis and differential diagnosis of graves’ disease. Pract Clin Med 2009: 2877-2878.
[10]	Liu BY, Yang BG, Fu SQ. Diagnosis of hashimoto’s thyroiditis with color doppler flow imaging. Chin Mel Imaging Techno 2008; 24:1920-1922.
[11]	Zhao R. Application of color doppler sonography on diagnosis and differential diagnosis of hyperthyroidism and subclinical hypothyroidism. Chinese J Ultrasound Med 2001; 17:3.
[12]	Diab N, Daya NR, Juraschek SP, Martin SS, McEvoy JW, Schulthei? UT, et al. Prevalence and risk factors of thyroid dysfunction in older adults in the community. Sci Rep 2019; 9:13156.
[13]	Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R et al. Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest 2005; 28:101-104.
[14]	Zhi M, Hou Z, We Q, Zhang Y, Li L, Yuan Y. Abnormal spontaneous brain activity is associated with impaired emotion and cognition in hyperthyroidism: A rs-fMRI study. Behav Brain Res 2018; 351:188-194.
[15]	Karakas O, Karakas E, Cullu N, Demir Y, Kucukyavas Y, Surucu E et al. An evaluation of thyrotoxic autoimmune thyroiditis patients with triplex doppler ultrasonography. Clin Imaging 2014; 38:1-5.
[16]	Hiraiwa T, Tsujimoto N, Tanimoto K, Terasaki J, Amino N, Hanafusa T. Use of color doppler ultrasonography to measure thyroid blood flow and differentiate graves' disease from painless thyroiditis. Eur Thyroid J 2013; 2:120-126.
[17]	Vita R, Di Bari F, Perelli S, Capodicasa G, Benvenga S. Thyroid vascularization is an important ultrasonographic parameter in untreated graves' disease patients. J Clin Transl Endocrino 2019; 15:65-69.
[18]	Uchida T, Shigihara N, Takeno K, Komiya K, Goto H, Abe H et al. Characteristics of patients with graves’ disease and intrathyroid hypovascularity compared to painless thyroiditis. J Ultrasound Med 2014; 33:1791-1796.
[19]	Goichot B, Leenhardt L, Massart C, Raverot V, Tramalloni J, Iraqi H. Consensus work-group. diagnostic procedure in suspected graves' disease. Ann Endocrinol (Paris). 2018; 79:608-617.
[20]	Varadhan L, Varughese GI, Sankaranarayanan S. Hyperthyroidism and graves' disease: Is an ultrasound examination needed? Indian J Endocrinol Metab 2016; 20:866-869.
[21]	Zandieh S, Bernt R, Zwerina J, Haller J, Knoll P, Seyeddain O et al. Acoustic structure quantification analysis of the thyroid in patients with diffuse autoimmune thyroid disease. Ultrason Imaging. 2016; 38:137-147.